Antioxidant therapy
Showing 1 - 25 of >10,000
Male Infertility Trial in Samsun (proxeed plus)
Completed
- Male Infertility
- proxeed plus
-
Samsun, TurkeyOndokuz Mayıs University
Sep 11, 2023
Tinnitus, Subjective, Tinnitus, Bilateral, Antioxidant Therapy Trial in Guadalajara (Drusen Mega®, Adepsique®, Placebo)
Recruiting
- Tinnitus, Subjective
- +5 more
- Drusen Mega®
- +2 more
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics,
Dec 13, 2022
Ulcerative Colitis Trial (MitoQ, Placebo)
Not yet recruiting
- Ulcerative Colitis
- MitoQ
- Placebo
- (no location specified)
Sep 13, 2022
Lower Extremity Lymphedema Trial in Ryazan' (Micronised purified flavonoid fraction (diosmin+flavonoids expressed as
Completed
- Lower Extremity Lymphedema
- Micronised purified flavonoid fraction (diosmin+flavonoids expressed as hesperidin)
- +2 more
-
Ryazan', Russian FederationRyazan State Medical University
Aug 3, 2022
Diabetic Retinopathy Trial in Guadalajara (Combined antioxidant therapy, Placebo)
Completed
- Diabetic Retinopathy
- Combined antioxidant therapy
- Placebo
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics,
Mar 21, 2022
Diabetic Retinopathy, Oxidative Stress, Diabetes Trial in Guadalajara (Combined antioxidant therapy, Placebo)
Completed
- Diabetic Retinopathy
- +2 more
- Combined antioxidant therapy
- Placebo
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics,
Mar 21, 2022
Vestibular Function Disorder Trial in San Antonio (Alpha Lipoic Acid 300mg, Coenzyme Q10 200mg)
Not yet recruiting
- Vestibular Function Disorder
- Alpha Lipoic Acid 300mg
- Coenzyme Q10 200mg
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Jul 5, 2023
Cardiovascular Diseases, Cardiovascular Risk Factor, Vasoconstriction Trial in Arlington (Control (Norepinephrine),
Recruiting
- Cardiovascular Diseases
- +2 more
- Control (Norepinephrine)
- +3 more
-
Arlington, TexasScience and Engineering Research and Innovation Building
Feb 7, 2022
Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial Trial in Santiago de Chile (Antioxidant
Recruiting
- Acute Myocardial Infarction
- +4 more
- Antioxidant formula
- Dextrose 5% in water
-
Santiago de Chile, ChileUniversity of Chile
Jan 17, 2022
Peripheral Diabetic Neuropathy Trial in Peshawar (Resveratrol, Alpha lipoic acid, Super oxide dismutase, Resveratrol, Alpha
Active, not recruiting
- Peripheral Diabetic Neuropathy
- Resveratrol, Alpha lipoic acid, Super oxide dismutase
- +3 more
-
Peshawar, KPK, PakistanSyed Hamid Habib
Nov 12, 2023
Periodontitis Trial in Baghdad (Root surface debridement)
Recruiting
- Periodontitis
- Root surface debridement
-
Baghdad, IraqCollege of Dentistry/ University of Baghdad
Aug 9, 2023
Neurofibromatosis 1 Trial in Cincinnati (N-Acetyl cysteine, Placebo)
Recruiting
- Neurofibromatosis 1
- N-Acetyl cysteine
- Placebo
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Feb 24, 2022
Oxidative Stress, Septic Shock Trial in Mexico City (Melatonin 5 mg, Vitamin C 1 GM Oral Tablet, Vitamin E 400 UNT)
Active, not recruiting
- Oxidative Stress
- Septic Shock
- Melatonin 5 mg
- +3 more
-
Mexico City, MexicoCentro Médico ABC
Aug 3, 2021
Anemia, Sickle Cell Trial in Oakland (alpha-lipoic acid and acetyl-L-carnitine, Control)
Completed
- Anemia, Sickle Cell
- alpha-lipoic acid and acetyl-L-carnitine
- Control
-
Oakland, CaliforniaChildren's Hospital & Research Center Oakland
Jul 13, 2021
HBOC Syndrome, DNA Damage, Nutrition Therapy Trial in Mexico City (Antioxidant therapy)
Active, not recruiting
- HBOC Syndrome
- +2 more
- Antioxidant therapy
-
Mexico City, Benito Juárez, MexicoMaría Fernanda Díaz Yáñez
Mar 23, 2022
Chronic Fatigue Syndrome, Myalgic Encephalomyelitis Trial in New York (NAC 900mg/day, NAC 3600mg/day, NAC 0mg/day (Placebo))
Recruiting
- Chronic Fatigue Syndrome
- Myalgic Encephalomyelitis
- NAC 900mg/day
- +2 more
-
New York, New YorkWeill Cornell Medicine
Jun 24, 2022
Leeches Trial in Alanya (leech therapy)
Completed
- Leeches
- leech therapy
-
Alanya, Antalya, TurkeyAlaaddin Keykubat University
Jun 28, 2022
Covid-19 Trial in Nigeria (Antioxidation Therapy, Standard of Care)
Withdrawn
- Covid-19
- Antioxidation Therapy
- Standard of Care
-
Umuahia, Abia State, Nigeria
- +10 more
Oct 29, 2021
Dry Eye Syndromes, Diabetic Retinopathy, Oxidative Stress Trial in Guadalajara (VisuXL®, Lagricel PF®, Humylub PF®)
Recruiting
- Dry Eye Syndromes
- +3 more
- VisuXL®
- +2 more
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics,
Jun 23, 2022
Periodontitis, Obstructive Sleep Apnea, OSAS Trial in Istanbul (Non-surgical periodontal therapy, Delayed non-surgical
Completed
- Periodontitis
- +2 more
- Non-surgical periodontal therapy
- Delayed non-surgical periodontal therapy
-
Istanbul, TurkeyBezmialem Vakıf University, Faculty of Dentistry, Deparment of P
Nov 8, 2021
Cardiovascular Diseases, Cardiovascular Risk Factor, Vasoconstriction Trial in Arlington (Control (Phenylephrine), Phenylephrine
Completed
- Cardiovascular Diseases
- +2 more
- Control (Phenylephrine)
- +3 more
-
Arlington, TexasScience and Engineering Research and Innovation Building
Nov 4, 2020
Pneumonia, Viral, Covid19, ARDS Trial in Mexico City (Vitamin C, Vitamin E, Melatonin)
Completed
- Pneumonia, Viral
- +3 more
- Vitamin C
- +4 more
-
Mexico City, MexicoUnidad Temporal COVID-19 en Centro Citibanamex
May 19, 2021
Oxidative Stress Trial in Ribeirao Preto (Taurine, Placebo)
Completed
- Oxidative Stress
- Taurine
- Placebo
-
Ribeirao Preto, Sao Paulo, BrazilEscola de Educação Física e Esporte de Ribeirão Preto
Dec 2, 2021
Neuromuscular Disease Trial run by the NINR (N-acetylcysteine, Placebo)
Completed
- Neuromuscular Disease
- N-acetylcysteine
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 9, 2019
Iron Overload, Oxidative Stress, Thalassemia Major Trial in Bani Suwayf, Mecca (Omega 3, Nigella Sativa Oil, Hydroxyurea)
Completed
- Iron Overload
- +2 more
- Omega 3
- +5 more
-
Banī Suwayf, Egypt
- +3 more
Jan 25, 2021